GPR35 and neoplasm: Blocking GPR35 signaling also reduces the secretion of angiogenic factors, including vascular endothelial growth factor (VEGF) and CXCL1, thereby inhibiting tumor angiogenesis and tumor cell proliferation (30) (Figure 1).